SB Drug Discovery's TRPML drug discovery platform delivers comprehensive solutions for advancing TRPML1, TRPML2 and TRPML3 research. With advanced cell-based assay capabilities and a full suite of technologies, including fluorescence-based assays, solid-supported...
Introduction Neurodegenerative disorders such as Alzheimer’s and Parkinson’s disease remain conditions with major unmet clinical needs. Abnormalities in the endosomal-autophagic-lysosomal system, progressive neurological dysfunction and regional neuronal loss...
Discover how our comprehensive TRP channel expertise and data-driven insights can expedite your CNS drug discovery research today. Introduction Glucose-dependent insulinotropic polypeptide (GIP) receptor, a member of the G protein-coupled receptor (GPCR) family,...